Cargando…
Economic burden of disease progression among multiple myeloma patients who have received transplant and at least one line of therapy in the US
Effects of disease progression on healthcare resource utilization (HRU) and costs among multiple myeloma (MM) patients with ≥1 line of therapy (LOT) who received their first stem cell transplant (SCT) within 1 year of initial MM diagnosis were estimated using a large US claims database. Disease prog...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093246/ https://www.ncbi.nlm.nih.gov/pubmed/33941766 http://dx.doi.org/10.1038/s41408-021-00431-5 |